Ignite Creation Date:
2024-05-06 @ 9:02 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02880605
Status:
COMPLETED
Last Update Posted:
2018-10-19
First Post:
2016-08-16
Brief Title:
Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization
Sponsor:
China National Center for Cardiovascular Diseases
Organization:
China National Center for Cardiovascular Diseases
Study Overview
Official Title:
Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Coronary revascularization CR is increasing rapidly in China and varies significantly in proportion PCICABG151 Few studies assess the appropriateness of CR in China Recently National Center for Cardiovascular Disease organized experts to release Chinese version appropriate use criteriaC-AUC for coronary revascularization by RAND method aimed at regulating indications of CR The criteria is considered to contribute to clinical practices quality assessment and health insurance policy however the validation of C-AUC is unknown
Thus the investigators study aims at assessing the validation of Chinese AUC by multi-center prospective registry The investigators will recruit 4000 patients undergoing elective coronary angiography with positive outcome consecutively and collect baseline information Sequently one-year follow up will be done to collect the prognose including death rehospitalization medicine medical compliance and life quality etc One hand the investigators will compare the outcomes between different therapies in the same indications according to C-AUC to evaluate the validation of C-AUC On the other hand the investigators will evaluate the rationality of CAD therapy in Beijing by C-AUC
Thus the investigators study aims at assessing the validation of Chinese AUC by multi-center prospective registry The investigators will recruit 4000 patients undergoing elective coronary angiography with positive outcome consecutively and collect baseline information Sequently one-year follow up will be done to collect the prognose including death rehospitalization medicine medical compliance and life quality etc One hand the investigators will compare the outcomes between different therapies in the same indications according to C-AUC to evaluate the validation of C-AUC On the other hand the investigators will evaluate the rationality of CAD therapy in Beijing by C-AUC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None